Needham cut Apellis Pharmaceuticals, Inc. APLS price target from $85 to $60. Needham analyst Joseph Stringer maintained a Buy ...
Lorraine Hutchinson, BofA Securities analyst, reiterated a Buy rating for LULU with a $355 price target. Data shows strong sales in China, reinforcing confidence in LULU's growth potential. China ...
The Cool Down on MSN2d
Iconic outdoor brand introduces new program to extend life of its products and lower prices for customers: 'It makes sense'Pre-Loved is a great way to save money and the planet. Iconic outdoor brand introduces new program to extend life of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback